‘Bosentan’ Approved by FDA to Treat Pulmonary Arterial Hypertension
source: pixabay.com

‘Bosentan’ Approved by FDA to Treat Pulmonary Arterial Hypertension

As originally reported in Global Data, the FDA has just given the final approval for a treatment options for pulmonary arterial hypertension (PAH) called 'Bosentan.' Pulmonary Arterial Hypertension Pulmonary Arterial Hypertension…

Continue Reading ‘Bosentan’ Approved by FDA to Treat Pulmonary Arterial Hypertension
First Personalized Medicine Trials for Cystic Fibrosis are Underway
source: pixabay.com

First Personalized Medicine Trials for Cystic Fibrosis are Underway

Proteostasis Therapeutics has just announced results from their ex-vivo study of PTI CFTR modulators using organoids from patients living with cystic fibrosis (CF). These organoids are genetically identical, and have…

Continue Reading First Personalized Medicine Trials for Cystic Fibrosis are Underway
Phase 2b Trial for Mitochondrial Diseases has Begun
source: pixabay.com

Phase 2b Trial for Mitochondrial Diseases has Begun

Khondrion has just announced that the very first patient has been dosed in their Phase 2b study for mitochondrial diseases called KHENERGYZE. This patient population has a high unmet need…

Continue Reading Phase 2b Trial for Mitochondrial Diseases has Begun
Close Menu